Characterization of proteasome inhibition on astrocytes cell cycle (Journal of Molecular Neuroscience DOI: 10.1007/s12031-008-9161-8);Characterization of proteasome inhibition on astrocytes cell cycle

Journal of Molecular Neuroscience

Volumn 38, Issue 1, 2009, Pages 57-66

  Ren, Qing Guo ^a,b   Yu, Ying ^a   Luo, Xiang ^a   Jie, Xie Min ^a   Pan, Deng Ji ^a   Wang, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Astrocytes; Cell cycle; IL 6; Proteasome; STAT 3

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; INTERLEUKIN 6; JANUS KINASE; LACTACYSTIN; PROTEASOME; STAT PROTEIN; STAT3 PROTEIN; ACETYLCYSTEINE; CELL CYCLE PROTEIN; CYSTEINE PROTEINASE INHIBITOR; DRUG DERIVATIVE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CYCLE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; SECRETION; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; ANIMALS; ASTROCYTES; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASES; CYSTEINE PROTEINASE INHIBITORS; HUMANS; INTERLEUKIN-6; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 68949207048     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-009-9183-x     Document Type: Erratum

References (40)

1. Baumeister, W., Walz, J., Zuhl, F., & Seemuller, E. (1998). The proteasome: paradigm of a self-compartmentalizing protease. Cell, 92, 367-380. doi:10.1016/S0092-8674(00)80929-0. (Pubitemid 28093014)
2. Bellido, T., O'Brien, C. A., Roberson, P. K., & Manolagas, S. C. (1998). Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their prodifferentiating and anti-apoptotic effects on human osteoblastic cells. The Journal of Biological Chemistry, 273, 21137-21144. doi:10.1074/jbc.273.33.21137. (Pubitemid 28385402)
3. Blagosklonny, M. V., Wu, G. S., Omura, S., & el-Deiry, W. S. (1996). Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochemical and Biophysical Research Communications, 227, 564-569. doi:10.1006/bbrc.1996.1546. (Pubitemid 26362843)
4. Butts, B. D., Hudson, H. R., Linseman, D. A., et al. (2005). Proteasome inhibition elicits a biphasic effect on neuronal apoptosis via differential regulation of pro-survival and proapoptotic transcription factors. Molecular and Cellular Neurosciences, 30, 279-289. doi:10.1016/j.mcn.2005.07.011. (Pubitemid 41316569)
5. Demasi, M., & Davies, K. J. (2003). Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygendependent mechanism. FEBS Letters, 542, 89-94. doi:10.1016/ S0014-5793(03)00353-363
6. Ding, Q., Dimayuga, E., Martin, S., et al. (2003). Characterization of chronic low-level proteasome inhibition on neural homeostasis. Journal of Neurochemistry, 86, 489-497. doi:10.1046/j.14714159.2003.01885.x.
7. Ding, Q., Bruce-Keller, A. J., Chen, Q., & Keller, J. N. (2004). Analysis of gene expression in neural cells subject to chronic proteasome inhibition. Free Radical Biology & Medicine, 36, 445-455. doi:10.1016/j.freeradbiomed.2003.10.025.
8. Evanko, D. S., Zhang, Q., Zorec, R., & Haydon, P. G. (2004). Defining pathways of loss and secretion of chemical messengers from astrocytes. Glia, 47, 233-240. doi:10.1002/glia.20050. (Pubitemid 39121068)
9. Fahrbach, S. E., & Schwartz, L. M. (1994). Localization of immunoreactive ubiquitin in the nervous system of the Manduca sexta moth. The Journal of Comparative Neurology, 343, 464-482. doi:10.1002/cne.903430309.
10. Flann, S., Hawkes, R. B., Riederer, B. M., Rider, C. C., & Beesley, P. W. (1997). Changes in ubiquitin immunoreactivity in developing rat brain: a putative role for ubiquitin and ubiquitin conjugates in dendrite outgrowth and differentiation. Neuroscience, 81, 173-187. doi:10.1016/S0306-4522(97)00196-6. (Pubitemid 27373637)
11. Fukada, T., Hibi, M., Yamanaka, Y., et al. (1996). Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity, 5, 449-460. doi:10.1016/S1074-7613(00)80501-4. (Pubitemid 26423473)
12. Haydon, P. G. (2001). GLIA: Listening and talking to the synapse. Nature Reviews. Neuroscience, 2, 185-193. doi:10.1038/ 35058528. (Pubitemid 33673371)
13. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., MüllerNewen, G., & Schaper, F. (2003). Principles of interleukin (IL)-6type cytokine signalling and its regulation. The Biochemical Journal, 374, 1-20. doi:10.1042/BJ20030407. (Pubitemid 37046923)
14. Hershko, A., & Ciechanover, A. (1998). The ubiquitin system. Annual Review of Biochemistry, 67, 425-479. doi:10.1146/annurev. biochem.67.1.425.
15. Kato, H., Takahashi, A., & Itoyama, Y. (2003). Cell cycle protein expression in proliferating microglia and astrocytes following transient global cerebral ischemia in the rat. Brain Research Bulletin, 60, 215-221. doi:10.1016/S0361-9230(03)00036-4. (Pubitemid 36561542)
16. Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000). Impaired proteasome function in Alzheimer's disease. Journal of Neurochemistry, 75, 436-439. doi:10.1046/j.1471-4159.2000.0750436.x. (Pubitemid 30418211)
17. Klausen, P., Pedersen, L., Jurlander, J., & Baumann, H. (2000). Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene, 19, 3675-3683. doi:10.1038/sj.onc.1203707.
18. Kliot, M., Smith, G. M., Siegal, J. D., & Silver, J. (1990). Astrocytepolymer implants promote regeneration of dorsal root fibers into the adult mammalian spinal cord. Experimental Neurology, 109, 57-69. doi:10.1016/S0014-4886(05)80008-1. (Pubitemid 20226705)
19. Kortylewski, M., Heinrich, P. C., Mackiewicz, A., et al. (1999). Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Oncogene, 18, 3742-3753. doi:10.1038/sj.onc.1202708. (Pubitemid 29338507)
20. Li, Z., Jansen, M., Pierre, S. R., & Figueiredo-Pereira, M. E. (2003). Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation. The International Journal of Biochemistry & Cell Biology, 35, 547-552. doi:10.1016/S13572725(02)00384-9.
21. Lopez Salon, M., Morelli, L., Castano, E. M., Soto, E. F., & Pasquini, J. M. (2000). Defective ubiquitination of cerebral proteins in Alzheimer's disease. Journal of Neuroscience Research, 62, 302-310. doi:10.1002/1097-4547(20001015)62:2<302::AIDJNR15>3.0.CO;2-L
22. Martinez-Vicente, M., Sovak, G., & Cuervo, A. M. (2005). Protein degradation and aging. Experimental Gerontology, 40, 622-633. doi:10.1016/j.exger.2005.07.005. (Pubitemid 41265812)
23. McNaught, K. S., Mytilineou, C., Jnobaptiste, R., et al. (2002). Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. Journal of Neurochemistry, 81, 301-306. doi:10.1046/j.1471-4159.2002.00821.x. (Pubitemid 34809355)
24. Moran, D. M., Mayes, N., Koniaris, L. G., Cahill, P. A., & McKillop, I. H. (2005). Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma. Liver International: Official Journal of the International Association for Study of the Liver, 25, 445-457.
25. Moran, D. M., Mattocks, M. A., Cahill, P. A., Koniaris, L. G., & McKillop, I. H. (2008). Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. The Journal of Surgical Research, 147, 23-33. doi:10.1016/j.jss.2007.04.022. (Pubitemid 351626069)
26. Nakanishi, M., Niidome, T., Matsuda, S., et al. (2007). Microgliaderived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. The European Journal of Neuroscience, 25, 649-658. doi:10.1111/j.1460-9568.2007.05309.x. (Pubitemid 46271169)
27. Nandi, D., Tahiliani, P. A., Kumar, D., & Chandu, D. (2006). The ubiquitin-proteasome system. Journal of Biosciences, 31, 137-155. doi:10.1007/BF02705243.
28. Niemand, C., Nimmesgern, A., Haan, S., et al. (2003). Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. Journal of Immunology (Baltimore, MD.: 1950), 170, 3263-3272.
29. Ortiz-Lazareno, P. C., Hernandez-Flores, G., Dominguez-Rodriguez, J. R., et al. (2008). MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: Involvement of nuclear factor-kappaB and activator protein-1. Immunology, 124, 534-541. doi:10.1111/j.1365-2567.2008.02806.x. (Pubitemid 351962549)
30. Panickar, K. S., & Norenberg, M. D. (2005). Astrocytes in cerebral ischemic injury: Morphological and general considerations. Glia, 50, 287-298. doi:10.1002/glia.20181. (Pubitemid 40780835)
31. Ren, Q. G., Liao, X. M., Chen, X. Q., Liu, G. P., & Wang, J. Z. (2007). Effects of tau phosphorylation on proteasome activity. FEBS Letters, 581, 1521-1528. doi:10.1016/j.febslet.2007.02.065. (Pubitemid 46454399)
32. Rideout, H. J., Zang, E., Yeasmin, M., et al. (2001). Inhibitors of trypsin-like serine proteases prevent DNA damage-induced neuronal death by acting upstream of the mitochondrial checkpoint and of p53 induction. Neuroscience, 107, 339-352. doi:10.1016/S0306-4522(01)00322-0. (Pubitemid 33145356)
33. Rideout, H. J., Wang, Q., Park, D. S., & Stefanis, L. (2003). Cyclindependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition. The Journal of Neuroscience, 23, 1237-1245.
34. Rockwell, P., Yuan, H., Magnusson, R., & Figueiredo-Pereira, M. E. (2000). Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2). Archives of Biochemistry and Biophysics, 374, 325-333. doi:10.1006/abbi.1999.1646. (Pubitemid 30120269)
35. Schumann, G., Huell, M., Machein, U., Hocke, G., & Fiebich, B. L. (1999). Interleukin-6 activates signal transducer and activator of transcription and mitogen-activated protein kinase signal transduction pathways and induces de novo protein synthesis in human neuronal cells. Journal of Neurochemistry, 73, 2009-2017.
36. Sherman, M. Y., & Goldberg, A. L. (2001). Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases. Neuron, 29, 15-32. doi:10.1016/S0896-6273(01) 00177-5.
37. Sinn, D. I., Lee, S. T., Chu, K., et al. (2007). Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib. Neuroscience Research, 58, 12-18. doi:10.1016/j.neures.2007.01.006. (Pubitemid 46695794)
38. Sun, K., Wilkins, D. E., Anver, M. R., et al. (2005). Differential effects of proteasome inhibition by bortezomib on murine acute graft-versushost disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity. Blood, 106, 3293-3299. doi:10.1182/blood-2004-11-4526. (Pubitemid 41565932)
39. Ullian, E. M., Harris, B. T., Wu, A., Chan, J. R., & Barres, B. A. (2004). Schwann cells and astrocytes induce synapse formation by spinal motor neurons in culture. Molecular and Cellular Neurosciences, 25, 241-251. doi:10.1016/j.mcn.2003.10.011. (Pubitemid 38338637)
40. Wojcik, C., & Di Napoli, M. (2004). Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. Stroke, 35, 1506-1518. doi:10.1161/01.STR.0000126891.93919.4e. (Pubitemid 38697484)